Loading…
ARKA Clinical Decision Support is designed to meet all four criteria for Non-Device CDS under FD&C Act §520(o)(1)(E) and FDA's January 2026 final guidance on Clinical Decision Support Software. Recommendations support, not replace, the clinician's judgment. Every recommendation is anchored in a published guideline or peer-reviewed source, with the basis available for independent review. CLIN emphasizes imaging appropriateness at order entry.
This recommendation is intended to support, not replace, clinical judgment. It is generated by ARKA, software designed to meet the four criteria for Non-Device Clinical Decision Support under FD&C Act §520(o)(1)(E) and FDA's final guidance on Clinical Decision Support Software (January 2026). The clinician is responsible for the final decision.
For the full-risk CFO
You own the margin on a full-risk medical group. Avoidable low-value imaging is not a payer's problem — it is retained or lost shared savings on your P&L. You buy the arithmetic: falsifiable baseline, contracted-rate dollars, payback you can show the board.
Your scorecard
The KPIs your board and leadership team track — where imaging leakage shows up first.
The problem
Benchmark-backed pain points tied to the metrics you own.
Full risk = your dollar
Fee-for-service write-off stories miss the point. Under full risk, low-value imaging hits the settlement.
Provenance required
A number without measured / modelled / illustrative provenance cannot enter the packet.
Lock or lose it
Without a locked pre-period, you cannot claim retained savings when utilization moves.
The fix
Each lever maps to a pain above — same order, same grid, so the pairing is obvious.
ROI keyed to attributed lives and total cost of care — not a denial-write-off story from a different buyer set.
Free baseline and LEAD brief give you a panel-specific arithmetic before any subscription.
Adding a sixth non-imaging service to a live contract is measured in engineer-hours with a published derivation — not a modeled retention slide.
The numbers
Modeled or published figures — labeled with their basis.
~$1M
avoidable / 100k lives
modelled — see ROI + LEAD brief
50–75%
retained under ACO tracks
modelled shared-savings retention
Falsifiable
pre-period lock
append-only baseline lock
Evidence
What we bring to the conversation — sourced from the ARKA buyer playbook.
Pushback
The concerns we hear most — and how we address them.
Open /roi with your attributed lives, then run the free baseline — the LEAD brief is the document you take to the board.
No — OpEx (PMPM). Module 1 needs no EHR capital project.
Different problem. Under full risk you are buying attributable avoided spend, not claim rework.
Your agenda
Three questions to put on the table — we'll answer with your data, not generic slides.
Question 1: What share of your book is full risk vs shared savings?
Question 2: Do you have a locked imaging pre-period today?
Question 3: What payback threshold does the board require?
Explore
Jump into the modules most relevant to your seat.
20-minute CFO briefing with the rebuilt ROI model and a LEAD brief for your attributed lives.
Quick answers
Open /roi for the arithmetic, then /lead for the LEAD brief keyed to your panel.
Public figures are labelled; your baseline produces measured trend against a locked pre-period.
20-minute CFO briefing with the rebuilt ROI model and a LEAD brief for your attributed lives.
